Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
A phase 1/2 trial of VB15010 in ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma, biliary tract cancer and colorectal cancer, run by Zhejiang Yangli Pharmaceutical Technology Co., Ltd., now recruiting.
Overview
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06819215 by Zhejiang Yangli Pharmaceutical Technology Co., Ltd., with 188 participants planned, started 2024-10-30 and due to reach its primary completion in 2025-12-30. Interventions recorded: VB15010.
Similar pages
not linked directly; found by shared links- TrialA Study of DM002 in Patients With Advanced Solid Tumors
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer and the tag pipeline.
- TrialA Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag pipeline.
- TrialA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
Shares Biliary tract cancer (cholangiocarcinoma), Ovarian cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
- TrialA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Shares Ovarian cancer, Prostate cancer, Colorectal cancer and the tag pipeline.
- TrialPhase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
Shares Biliary tract cancer (cholangiocarcinoma), Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag pipeline.
- TrialPhase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer and the tag pipeline.
- TrialA Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Shares Biliary tract cancer (cholangiocarcinoma), Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.